Columbia Care Inc. is a cultivator, manufacturer and provider of cannabis products and related services. The Company’s principal business activity is the production and sale of cannabis. The Company operates approximately 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities. The Company offers products such as spanning flower, edibles, oils, and tablets. It manufactures brands which include Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber and Platinum Label Cannabidiol (CBD). The Company, through its subsidiaries, owns or manages interests in state-licensed medical and/or adult use marijuana businesses in Arizona, California, Colorado, Delaware, European Union, Florida, Illinois, Maryland, Massachusetts, Missouri, New Jersey, New York and Puerto Rico, among others. The Company’s subsidiaries include 203 Organix, L.L.C., Columbia Care - Arizona, Tempe, L.L.C., Columbia Care-Arizona, Prescott, L.L.C. and Salubrious Wellness Clinic, Inc.
No company officers listed.
No insider trading activity.
Insider trading information report provided by Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.